openPR Logo
Press release

Carbamazepine Market detailed assessment of dynamic growth 2025

06-01-2018 06:06 AM CET | Health & Medicine

Press release from: TMR Research

/ PR Agency: TMR Research
Carbamazepine Market detailed assessment of dynamic growth

Global Carbamazepine Market: Snapshot

Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the commercial use in the U.S., aiming to serve adult patients who are unable to take oral carbamazepine due to conditions such as gegneralized tonic-clonic seizures, partial seizures with complex symptomatology, and toehr mixed seizure patterns. Consequently, the demand in the global carbamazepine market is expected to expand at a healthy growth rate during the forecast period of 2017 to 2025. On the other hand, as is the case with oral carbamazepine products, the risk of severe dermatologic reactions during treatment processes with Carnexiv, such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) as well as the possibilities of agranulocytosis and aplastic anemia. These factors are expected to hinder the growth rate of the carbamazepine market.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=446

This report on the global carbamazepine market has been prepared to serve as a reliable business document for stakeholders of the market such as pharmaceutical companies, suppliers and distributors, and government agencies. All the important factors that are anticipated to increase or decrease the demand in the carbamazepine market have been comprehensively analyzed, and their final impacts have been estimated. The report also profiles some of the leading companies operating in this market in order to present a picture of the competitive landscape in its current scenario, and estimates the future until 2025. The report also takes stock of all the recent developments pertaining to carbamazepine market in order to complete a thorough study.

Global Carbamazepine Market: Overview

Carbamazepine sold under the brand names of Carbatrol, Epitol, Tegretol, Equetro, and TEGretol-XR., is a drug used primarily for the treatment of epilepsy and neuropathic pain. It is also used for schizophrenia as an alternate line of treatment as well as for bipolar disorder. The increasing demand for carbamazepine for the treatment of various types of seizures and bipolar disorders is expected to drive the global carbamazepine market in the next few years.

Carbamazepine is a white or yellowish-white crystalline powder, which is almost odorless. Carbamazepine is tasteless or has a slightly bitter taste. Carbamazepine are available as chewable tablet, suspension, tablet, extended release tablet, and extended release capsule.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=446

Carbamazepine is suitable for the treatment of status epilepticus. Moreover, carbamazepine is utilized in the treatment of trigeminal neuralgia. Carbamazepine is utilized for the pain relief of idiopathic trigeminal and trigeminal neuralgia due to multiple sclerosis and also for the pain relief of idiopathic glossopharyngeal neuralgia. However, carbamazepine is not a simple analgesic and is not suitable to be used for trivial facial pain or headache. Moreover, carbamazepine is used for the treatment of mania and for maintaining the treatment of bipolar affective disorders or to prevent recurrence. However, carbamazepine is not effective in treating absence seizures, myoclonic seizures, and atonic seizures. Also, carbamazepine is not suitable for treating status epilepticus.

The report presents a detailed assessment of the market dynamics, growth trends, and opportunities that will impact the progression of the global carbamazepine market between 2017 and 2025. The report has been collated using primary and secondary research methodologies to present an exact case of this market. The report is focused on presenting a granular view of the various market segments along with the factors influencing them.

Read Comprehensive Overview of Report @ https://www.tmrresearch.com/carbamazepine-market

The report discuss the vendor landscape of the global carbamazepine market at length. This includes a competitive profile of the key vendors pertaining to their attributes of product specification and portfolio, financial standing, and recent developments. It also includes an analysis of the indices of strengths, weakness, opportunities, and threats of these vendors during the forecast period. Finally, the report includes comments and recommendations from industry experts for new and existing players.

Global Carbamazepine Market: Trends and Opportunities

The FDA has approved the medical use of carbamazepine for epilepsy, manic episodes of bipolar disorders, and trigeminal neuralgia. A controlled release formulation about carbamazepine was available by the FDA as of 2014, which provides tentative evidence regarding fewer side effects of the drug.

The dynamic growth of the epilepsy market with the increasing number of cases in the mid-teen age group is presenting lucrative growth opportunities to the carbamazepine market. For instance, in the U.S., the use of newer therapies for epilepsy and bipolar depression has witnessed a fourfold increase. The increasing number of individuals suffering from alcohol withdrawal disorders, central partial diabetes insipidus or water diabetes, and psychotic disorders is also driving the carbamazepine market.

Major Companies Mentioned in Report

Some of the leading players in the carbamazepine market are Novartis AG, Jubilant Pharma, Jiangsu Tohope, Shanghai Modern Hasen, Zhejiang Jiuzhou, and Jinan Jinda.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carbamazepine Market detailed assessment of dynamic growth 2025 here

News-ID: 1067674 • Views: 158

More Releases from TMR Research

Lung Infections Market Challenging Health Concerns 2025 | Bayer AG, Insmed Incor …
Lung Infections Market: Snapshot The treatment for lung infections has conventionally been led by small molecule therapies. These therapies however, were aimed to treat the symptoms of lung infections, rather than the actual cause of the infection. This has led to the emergence of diverse treatment options, which differ in terms of their targets and their action mechanism. Many past cases exist, where a patient has been given a combination
RFID in Pharmaceuticals Market Challenges On Upcoming Trends 2025 | IBM Corporat …
Global RFID in Pharmaceuticals Market: Snapshot The U.S. Food and Drug Administration (FDA) has played a vital role in escalating the widespread adoption of Radio Frequency Identification (RFID) in the pharmaceutical sector to strengthen anti-counterfeiting and track-and-trace efforts. Besides these benefits, RFID technology is acknowledged for its ability to increase supply chain efficiency, reduce errors by proper storage of information, boost patient safety and monitoring, enhance staff, patient, and asset
Tapentadol Market Analysis On Trends and Need 2025 | Johnson & Johnson Pharmaceu …
Global Tapentadol Market: Snapshot The growing prevalence of chronic diseases is leading to the high occurrence of chronic musculoskeletal pain, which is likely to create an upswing in the demand for tapentadol worldwide. Tapentadol is also used for the treatment of moderate to severe acute pain. The potency of this treatment lies somewhere between that of morphine and tramadol. Despite the lower occurrence of side effects, its analgesic efficacy is
Gingivitis Diagnostics and Therapeutics Market 2025 | General Biologicals Corp a …
Global Gingivitis Diagnostics and Therapeutics Market: Snapshot The global market for gingivitis diagnostics and therapeutics is expected to witness growth at a significant rate in the next few years owing to factors such as the rising number of smokers, women of reproductive age, and obese people across the globe. The market is highly dynamic in terms of technologies used for diagnosing and treating gingivitis, one of the most common periodontal conditions

All 5 Releases


More Releases for Carbamazepine

Carbamazepine Market -Trends and Opportunities 2025 | Jubilant Pharma, Jiangsu T …
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market Bestowing Current Demand till 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market Dynamic Growth Rate by 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market : Industry Analysis,Trends and Forecast 2017 - 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market – Companies, applications, products and more 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market : Professional Market Research Report and Forecasts, 2017 - …
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the